RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eli Lilly and Co Stock

Eli Lilly and Co Dividend 2024

Eli Lilly and Co Dividend

4.52 USD

Eli Lilly and Co Dividend yield

0.54 %

Ticker

LLY

ISIN

US5324571083

WKN

858560

How much dividend does Eli Lilly and Co 2024 pay?

According to the latest status from December 2024, Eli Lilly and Co paid a total of 4.52 USD per share in dividends within the last 12 months. With the current Eli Lilly and Co price of 829.84 USD, this corresponds to a dividend yield of 0.54 %. A dividend is paid 4 times per year.

0.54 % Dividend Yield=
4.52 USD Dividend
829.84 USD Stock Price

Historical Eli Lilly and Co Dividends

A dividend is paid 4 times per year. Last year, the payout months were March, June, September and December.

PaydateDividend
12/15/20241.3
9/15/20241.3
6/15/20241.3
3/14/20241.3
12/14/20231.13
9/14/20231.13
6/12/20231.13
3/14/20231.13
12/14/20220.98
9/12/20220.98
6/13/20220.98
3/14/20220.98
12/12/20210.85
9/12/20210.85
6/13/20210.85
3/11/20210.85
12/12/20200.74
9/13/20200.74
6/14/20200.74
3/13/20200.74
1
2
3
4
5
...
8

Eli Lilly and Co dividend history and estimates

In 2023, Eli Lilly and Co paid a dividend amounting to 4.52 USD. Dividend means that Eli Lilly and Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Eli Lilly and Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Eli Lilly and Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Eli Lilly and Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Eli Lilly and Co Dividend History

DateEli Lilly and Co Dividend
2029e5.74 undefined
2028e5.73 undefined
2027e5.73 undefined
2026e5.75 undefined
2025e5.73 undefined
2024e5.72 undefined
20234.52 undefined
20223.92 undefined
20213.4 undefined
20202.96 undefined
20192.58 undefined
20182.25 undefined
20172.08 undefined
20163.06 undefined
20152.5 undefined
20141.96 undefined
20131.96 undefined
20121.96 undefined
20111.96 undefined
20101.96 undefined
20091.96 undefined
20081.88 undefined
20071.7 undefined
20061.6 undefined
20051.52 undefined
20041.42 undefined

Is the Eli Lilly and Co Dividend Safe?

Eli Lilly and Co has been increasing the dividend for 6 years.

Over the past 10 years, Eli Lilly and Co has increased it by an annual 8.715 %.

Over a five-year period, the distribution increased by 14.972%.

Analysts expect a Dividend Increase of 12.478% for the current fiscal year.

Eli Lilly and Co dividend payout ratio

In 2023, Eli Lilly and Co had a payout ratio of 51.99%. The payout ratio indicates the percentage of the company's profits that Eli Lilly and Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Eli Lilly and Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Eli Lilly and Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Eli Lilly and Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Eli Lilly and Co Payout Ratio History

DateEli Lilly and Co Payout ratio
2029e54.11 %
2028e54.22 %
2027e54.36 %
2026e53.77 %
2025e54.53 %
2024e54.78 %
202351.99 %
202256.81 %
202155.56 %
202043.59 %
201929.05 %
201872.12 %
2017-1,094.74 %
2016118.6 %
2015110.62 %
201487.89 %
201345.37 %
201253.55 %
201150.26 %
201042.79 %
200949.75 %
2008-99.47 %
200762.73 %
200665.31 %
200583.06 %
200485.54 %

Dividend Details

Understanding Eli Lilly and Co's Dividend Distributions

Eli Lilly and Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Eli Lilly and Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Eli Lilly and Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Eli Lilly and Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Eli Lilly and Co Aktienanalyse

What does Eli Lilly and Co do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Frequently Asked Questions about Eli Lilly and Co stock

How much dividend does Eli Lilly and Co pay?

Over the past 12 months, Eli Lilly and Co paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.54 %. For the coming 12 months, Eli Lilly and Co is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and Co?

The current dividend yield of Eli Lilly and Co is 0.54 %.

When does Eli Lilly and Co pay dividends?

Eli Lilly and Co pays a quarterly dividend. This is distributed in the months of March, June, September, December.

How secure is the dividend of Eli Lilly and Co?

Eli Lilly and Co paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and Co?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.69 %.

In which sector is Eli Lilly and Co located?

Eli Lilly and Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and Co from 12/10/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Eli Lilly and Co pay the last dividend?

The last dividend was paid out on 12/10/2024.

What was the dividend of Eli Lilly and Co in the year 2023?

In the year 2023, Eli Lilly and Co distributed 3.92 USD as dividends.

In which currency does Eli Lilly and Co pay out the dividend?

The dividends of Eli Lilly and Co are distributed in USD.

Andere Kennzahlen von Eli Lilly and Co

Our stock analysis for Eli Lilly and Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.